Eaton Vance Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $431K | Sell |
8,015
-40
| -0.5% | -$2.15K | ﹤0.01% | 1367 |
|
|
2022
Q2 | $448K | Sell |
8,055
-1,060
| -12% | -$59K | ﹤0.01% | 1392 |
|
|
2022
Q1 | $639K | Sell |
9,115
-556
| -6% | -$39K | ﹤0.01% | 1467 |
|
|
2021
Q4 | $932K | Buy |
9,671
+96
| +1% | +$9.25K | ﹤0.01% | 1192 |
|
|
2021
Q3 | $697K | Buy |
9,575
+734
| +8% | +$53.4K | ﹤0.01% | 1162 |
|
|
2021
Q2 | $724K | Buy |
8,841
+746
| +9% | +$61.1K | ﹤0.01% | 1260 |
|
|
2021
Q1 | $770K | Sell |
8,095
-536,390
| -99% | -$51M | ﹤0.01% | 1184 |
|
|
2020
Q4 | $33.8M | Buy |
544,485
+161,439
| +42% | +$10M | 0.05% | 323 |
|
|
2020
Q3 | $22.8M | Buy |
383,046
+39,292
| +11% | +$2.34M | 0.04% | 339 |
|
|
2020
Q2 | $24M | Buy |
343,754
+48,257
| +16% | +$3.37M | 0.05% | 307 |
|
|
2020
Q1 | $13.4M | Buy |
295,497
+22,150
| +8% | +$1M | 0.03% | 355 |
|
|
2019
Q4 | $17.8M | Buy |
273,347
+58,970
| +28% | +$3.84M | 0.03% | 352 |
|
|
2019
Q3 | $13.3M | Buy |
214,377
+24,731
| +13% | +$1.54M | 0.03% | 388 |
|
|
2019
Q2 | $13.5M | Buy |
189,646
+76,325
| +67% | +$5.44M | 0.03% | 374 |
|
|
2019
Q1 | $8.89M | Sell |
113,321
-784
| -0.7% | -$61.5K | 0.02% | 440 |
|
|
2018
Q4 | $9.66M | Buy |
114,105
+15,397
| +16% | +$1.3M | 0.03% | 373 |
|
|
2018
Q3 | $16.9M | Sell |
98,708
-23,744
| -19% | -$4.07M | 0.04% | 305 |
|
|
2018
Q2 | $15.8M | Sell |
122,452
-224,331
| -65% | -$29M | 0.04% | 312 |
|
|
2018
Q1 | $35.7M | Buy |
346,783
+122,292
| +54% | +$12.6M | 0.04% | 293 |
|
|
2017
Q4 | $19.2M | Sell |
224,491
-70,352
| -24% | -$6.01M | 0.05% | 282 |
|
|
2017
Q3 | $25M | Sell |
294,843
-23,250
| -7% | -$1.97M | 0.06% | 238 |
|
|
2017
Q2 | $24.1M | Sell |
318,093
-361
| -0.1% | -$27.3K | 0.06% | 236 |
|
|
2017
Q1 | $21M | Buy |
318,454
+171,162
| +116% | +$11.3M | 0.06% | 244 |
|
|
2016
Q4 | $9.34M | Buy |
147,292
+112,852
| +328% | +$7.15M | 0.03% | 321 |
|
|
2016
Q3 | $2.19M | Buy |
+34,440
| New | +$2.19M | 0.01% | 569 |
|